LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 58.15 | 27.76 | 7575 | 5906 | 1.2825 | 1.0654 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 58.15 | 27.76 | 7652 | 5906 | 1.2955 | 1.0681 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 59.85 | 27.76 | 5615 | 6062 | 0.9262 | 0.9804 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 59.85 | 27.76 | 5765 | 6062 | 0.9509 | 0.9871 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 59.85 | 27.76 | 7858 | 6062 | 1.2961 | 1.0679 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 59.85 | 27.76 | 7946 | 6062 | 1.3106 | 1.0709 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 61.56 | 27.76 | 5822 | 6217 | 0.9364 | 0.9833 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 61.56 | 27.76 | 5979 | 6217 | 0.9617 | 0.9900 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 61.56 | 27.76 | 8052 | 6217 | 1.2951 | 1.0674 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 61.56 | 27.76 | 8231 | 6217 | 1.3239 | 1.0732 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 63.26 | 27.76 | 6138 | 6465 | 0.9493 | 0.9868 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 63.26 | 27.76 | 6276 | 6465 | 0.9707 | 0.9924 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 63.26 | 27.76 | 8370 | 6465 | 1.2945 | 1.0667 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 63.26 | 27.76 | 8486 | 6465 | 1.3125 | 1.0704 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 64.97 | 27.76 | 6350 | 6656 | 0.9539 | 0.9881 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 64.97 | 27.76 | 6462 | 6656 | 0.9707 | 0.9925 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 64.97 | 27.76 | 8578 | 6656 | 1.2886 | 1.0652 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 64.97 | 27.76 | 8694 | 6656 | 1.3060 | 1.0687 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 66.67 | 27.76 | 6560 | 6695 | 0.9797 | 0.9948 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 66.67 | 27.76 | 6687 | 6695 | 0.9987 | 0.9997 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 66.67 | 27.76 | 8815 | 6695 | 1.3165 | 1.0707 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 66.67 | 27.76 | 8935 | 6695 | 1.3344 | 1.0743 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 68.37 | 27.76 | 6708 | 6879 | 0.9751 | 0.9937 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 68.37 | 27.76 | 6912 | 6879 | 1.0048 | 1.0012 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 68.37 | 27.76 | 8933 | 6879 | 1.2985 | 1.0668 | MN20160318_Q01 | J07 |